Recent preliminary CDC data showing sharp year-over-year drops in January and February 2026 births—down 4.8% and 2.15% respectively—has solidified trader consensus that the U.S. general fertility rate will not rise in Q1 compared to the prior quarter's 53.3 benchmark. This continues the steady downward trajectory confirmed in April's provisional 2025 report, where the annual rate hit a record low of 53.1 births per 1,000 women aged 15-44 amid long-running factors like delayed childbearing, economic pressures, and below-replacement patterns persisting since 2007. With no reversal signals in early monthly figures, traders view an increase as unlikely, awaiting the next CDC Vital Statistics Rapid Release for final confirmation while noting the market's strong implied probability for no uptick reflects these sustained demographic headwinds.
Ringkasan eksperimental yang dihasilkan AI dengan referensi data Polymarket. Ini bukan saran trading dan tidak berperan dalam bagaimana pasar ini diselesaikan. · DiperbaruiUS fertility rate up in Q1 2026?
US fertility rate up in Q1 2026?
BARU
BARU
Dec 31, 2026
BARU
BARU
Dec 31, 2026
The CDC estimates a general fertility rate of 53.3 births per 1,000 women aged 15–44 for Q4 2025 (see: https://www.cdc.gov/nchs/nvss/vsrr/natality-dashboard.htm).
This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No".
If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No".
Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions.
The resolution source will be the CDC’s Vital Statistics Rapid Release.Recent preliminary CDC data showing sharp year-over-year drops in January and February 2026 births—down 4.8% and 2.15% respectively—has solidified trader consensus that the U.S. general fertility rate will not rise in Q1 compared to the prior quarter's 53.3 benchmark. This continues the steady downward trajectory confirmed in April's provisional 2025 report, where the annual rate hit a record low of 53.1 births per 1,000 women aged 15-44 amid long-running factors like delayed childbearing, economic pressures, and below-replacement patterns persisting since 2007. With no reversal signals in early monthly figures, traders view an increase as unlikely, awaiting the next CDC Vital Statistics Rapid Release for final confirmation while noting the market's strong implied probability for no uptick reflects these sustained demographic headwinds.
The CDC estimates a general fertility rate of 53.3 births per 1,000 women aged 15–44 for Q4 2025 (see: https://www.cdc.gov/nchs/nvss/vsrr/natality-dashboard.htm).
This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No".
If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No".
Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions.
The resolution source will be the CDC’s Vital Statistics Rapid Release.
This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No".
If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No".
Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions.
The resolution source will be the CDC’s Vital Statistics Rapid Release.
Pasar Dibuka: Apr 27, 2026, 4:53 PM ET
Volume
$72Tanggal Berakhir
Dec 31, 2026Pasar Dibuka
Apr 27, 2026, 4:53 PM ETResolver
0x65070BE91...The CDC estimates a general fertility rate of 53.3 births per 1,000 women aged 15–44 for Q4 2025 (see: https://www.cdc.gov/nchs/nvss/vsrr/natality-dashboard.htm).
This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No".
If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No".
Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions.
The resolution source will be the CDC’s Vital Statistics Rapid Release.Recent preliminary CDC data showing sharp year-over-year drops in January and February 2026 births—down 4.8% and 2.15% respectively—has solidified trader consensus that the U.S. general fertility rate will not rise in Q1 compared to the prior quarter's 53.3 benchmark. This continues the steady downward trajectory confirmed in April's provisional 2025 report, where the annual rate hit a record low of 53.1 births per 1,000 women aged 15-44 amid long-running factors like delayed childbearing, economic pressures, and below-replacement patterns persisting since 2007. With no reversal signals in early monthly figures, traders view an increase as unlikely, awaiting the next CDC Vital Statistics Rapid Release for final confirmation while noting the market's strong implied probability for no uptick reflects these sustained demographic headwinds.
The CDC estimates a general fertility rate of 53.3 births per 1,000 women aged 15–44 for Q4 2025 (see: https://www.cdc.gov/nchs/nvss/vsrr/natality-dashboard.htm).
This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No".
If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No".
Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions.
The resolution source will be the CDC’s Vital Statistics Rapid Release.
This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No".
If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No".
Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions.
The resolution source will be the CDC’s Vital Statistics Rapid Release.
Volume
$72Tanggal Berakhir
Dec 31, 2026Pasar Dibuka
Apr 27, 2026, 4:53 PM ETResolver
0x65070BE91...Recent preliminary CDC data showing sharp year-over-year drops in January and February 2026 births—down 4.8% and 2.15% respectively—has solidified trader consensus that the U.S. general fertility rate will not rise in Q1 compared to the prior quarter's 53.3 benchmark. This continues the steady downward trajectory confirmed in April's provisional 2025 report, where the annual rate hit a record low of 53.1 births per 1,000 women aged 15-44 amid long-running factors like delayed childbearing, economic pressures, and below-replacement patterns persisting since 2007. With no reversal signals in early monthly figures, traders view an increase as unlikely, awaiting the next CDC Vital Statistics Rapid Release for final confirmation while noting the market's strong implied probability for no uptick reflects these sustained demographic headwinds.
Ringkasan eksperimental yang dihasilkan AI dengan referensi data Polymarket. Ini bukan saran trading dan tidak berperan dalam bagaimana pasar ini diselesaikan. · Diperbarui
Hati-hati dengan link eksternal.
Hati-hati dengan link eksternal.
Pertanyaan yang Sering Diajukan